176 related articles for article (PubMed ID: 19254397)
1. Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer.
Seabra D; Faria E; Dauster B; Rodrigues G; Fava G
Int Braz J Urol; 2009; 35(1):43-8. PubMed ID: 19254397
[TBL] [Abstract][Full Text] [Related]
2. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
3. [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
Vidmar R; Marcq G; Flamand V; Fantoni JC; Hénon F; Villers A; Ouzzane A
Prog Urol; 2017; 27(8-9):458-466. PubMed ID: 28576424
[TBL] [Abstract][Full Text] [Related]
4. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
Heidenreich A; Richter S; Thüer D; Pfister D
Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
[TBL] [Abstract][Full Text] [Related]
5. Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications.
Rosoff JS; Savage SJ; Prasad SM
World J Urol; 2013 Dec; 31(6):1347-52. PubMed ID: 23358790
[TBL] [Abstract][Full Text] [Related]
6. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA
Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229
[TBL] [Abstract][Full Text] [Related]
7. Sequential treatment for recurrent localized prostate cancer.
Van Der Poel HG; Moonen L; Horenblas S
J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of salvage radical prostatectomy following more than one failed local therapy.
Sivaraman A; Scardino P; Eastham J
Investig Clin Urol; 2018 May; 59(3):152-157. PubMed ID: 29744471
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
van Riel LAMJG; Geboers B; Kabaktepe E; Blazevski A; Reesink DJ; Stijns P; Stricker PD; Casanova J; Dominguez-Escrig JL; de Reijke TM; Scheltema MJ; Oddens JR
BJU Int; 2022 Nov; 130(5):611-618. PubMed ID: 35474600
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
[TBL] [Abstract][Full Text] [Related]
11. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
Vaidya A; Soloway MS
J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
[TBL] [Abstract][Full Text] [Related]
12. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
Chade DC; Eastham J; Graefen M; Hu JC; Karnes RJ; Klotz L; Montorsi F; van Poppel H; Scardino PT; Shariat SF
Eur Urol; 2012 May; 61(5):961-71. PubMed ID: 22280856
[TBL] [Abstract][Full Text] [Related]
13. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
[TBL] [Abstract][Full Text] [Related]
14. Perineal salvage prostatectomy for radiation resistant prostate cancer.
van der Poel HG; Beetsma DB; van Boven H; Horenblas S
Eur Urol; 2007 Jun; 51(6):1565-71; discussion 1572. PubMed ID: 16949728
[TBL] [Abstract][Full Text] [Related]
15. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
[TBL] [Abstract][Full Text] [Related]
16. Salvage radical prostatectomy: an alternative treatment for local recurrence of radioresistant cancer.
Dall'Oglio MF; Barreto F; Paranhos M; Nesrallah A; Nesrallah L; Srougi M
Int Braz J Urol; 2006; 32(5):550-6. PubMed ID: 17081323
[TBL] [Abstract][Full Text] [Related]
17. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
Raj GV; Partin AW; Polascik TJ
Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467
[TBL] [Abstract][Full Text] [Related]
19. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
[TBL] [Abstract][Full Text] [Related]
20. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
Gontero P; Marra G; Alessio P; Filippini C; Oderda M; Munoz F; Linares E; Sanchez-Salas R; Challacombe B; Dasgupta P; Goonewardene S; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Piechaud T; Morlacco A; Vidit S; Rouprêt M; De La Taille A; Albisinni S; Gandaglia G; Mottrie A; Joshi S; Fiscus G; Berger A; Aron M; Van Der Poel H; Tilki D; Lawrentschuk N; Murphy DG; Leung G; Davis J; Karnes RJ;
J Urol; 2019 Oct; 202(4):725-731. PubMed ID: 31075058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
